Perceptive Advisors’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-524,088
| Closed | -$55.9M | – | 129 |
|
|
2025
Q3 | $55.9M | Sell |
524,088
-4,983,503
| -90% | -$520M | 1.61% | 20 |
|
|
2025
Q2 | $521M | Sell |
5,507,591
-1,055,749
| -16% | -$78.2M | 19.31% | 1 |
|
|
2025
Q1 | $417M | Buy |
6,563,340
+171,234
| +3% | +$10.2M | 14.72% | 1 |
|
|
2024
Q4 | $297M | Buy |
6,392,106
+76,173
| +1% | +$2.86M | 8.18% | 1 |
|
|
2024
Q3 | $182M | Buy |
6,315,933
+3,882,208
| +160% | +$95.5M | 3.84% | 7 |
|
|
2024
Q2 | $35.2M | Sell |
2,433,725
-1,327,851
| -35% | -$19.4M | 0.85% | 35 |
|
|
2024
Q1 | $60.5M | Sell |
3,761,576
-104,638
| -3% | -$1.81M | 1.06% | 32 |
|
|
2023
Q4 | $76.9M | Sell |
3,866,214
-140,983
| -4% | -$2.08M | 1.72% | 16 |
|
|
2023
Q3 | $65.3M | Sell |
4,007,197
-389,919
| -9% | -$7.51M | 2.18% | 13 |
|
|
2023
Q2 | $93M | Buy |
4,397,116
+1,663,326
| +61% | +$35.5M | 2.69% | 9 |
|
|
2023
Q1 | $54.9M | Sell |
2,733,790
-2,146,929
| -44% | -$46.4M | 1.62% | 18 |
|
|
2022
Q4 | $128M | Sell |
4,880,719
-166,545
| -3% | -$2.22M | 3.58% | 6 |
|
|
2022
Q3 | $51.6M | Buy |
5,047,264
+2,132,118
| +73% | +$18M | 1.5% | 18 |
|
|
2022
Q2 | $12.2M | Sell |
2,915,146
-129,157
| -4% | -$552K | 0.38% | 55 |
|
|
2022
Q1 | $15.2M | Buy |
3,044,303
+176,793
| +6% | +$1.03M | 0.3% | 65 |
|
|
2021
Q4 | $19.3M | Sell |
2,867,510
-21,379
| -0.7% | -$109K | 0.3% | 68 |
|
|
2021
Q3 | $15.8M | Hold |
2,888,889
| – | – | 0.23% | 78 |
|
|
2021
Q2 | $18.9M | Hold |
2,888,889
| – | – | 0.25% | 85 |
|
|
2021
Q1 | $24.2M | Hold |
2,888,889
| – | – | 0.31% | 70 |
|
|
2020
Q4 | $20.2M | Hold |
2,888,889
| – | – | 0.22% | 84 |
|
|
2020
Q3 | $18M | Buy |
+2,888,889
| New | +$20M | 0.26% | 71 |
|
|
2018
Q3 | – | Sell |
-22,327
| Closed | -$307K | – | 133 |
|
|
2018
Q2 | $307K | Sell |
22,327
-33,841
| -60% | -$569K | 0.01% | 116 |
|
|
2018
Q1 | $1.12M | Sell |
56,168
-143,832
| -72% | -$2.08M | 0.03% | 106 |
|
|
2017
Q4 | $2.38M | Hold |
200,000
| – | – | 0.08% | 87 |
|
|
2017
Q3 | $3.07M | Hold |
200,000
| – | – | 0.12% | 83 |
|
|
2017
Q2 | $2.33M | Buy |
+200,000
| New | +$2.65M | 0.12% | 79 |
|
Other funds holding VRNA
Perceptive Advisors's VRNA Position: Q4 2025 in Review
Perceptive Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 524,088 shares — an estimated $55.9M sold.
Perceptive Advisors first reported a position in VRNA in Q2 2017 and held it in 26 quarters. The position peaked at $521M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Perceptive Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Perceptive Advisors sold 524,088 Verona Pharma shares in Q4 2025, an estimated $55.9M.
- Perceptive Advisors first reported a position in Verona Pharma in Q2 2017 and held it in 26 quarters.
- Perceptive Advisors's Verona Pharma position peaked at $521M in Q2 2025.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Perceptive Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.